CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Peter Galettis - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Peter Galettis

OPENALEX: A5056481563↗ORCID: 0000-0002-6785-2529↗

Affiliations

Organizations

Australian Institute of Nuclear Science and Engineeringauthorship · AU Hunter Medical Research Instituteauthorship · AU University of Newcastle Australiaauthorship · AU

Public evidence

4 connected articles

Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.2022 · Europe PMC Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users.2018 · Europe PMC Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting.2018 · Europe PMC Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial.2018 · Europe PMC

Registered research

Connected studies

Effects of Cannabidiol (CBD) on the Brainnct04831294

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.